4D Molecular Therapeutics Inc Dividends
The next dividend date for 4D Molecular Therapeutics Inc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for 4D Molecular Therapeutics Inc (FDMT)
More About 4D Molecular Therapeutics Inc
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. Its lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. The company is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in in preclinical stage for treating geographic atrophy; 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease; and 4D-310 that is in Phase 1 clinical trial for treating Fabry disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Astellas Gene Therapies, Inc.; Arbor Biotechnologies, Inc.; and uniQure biopharma B.V. The company was founded in 2013 and is headquartered in Emeryville, California.
Owning 4D Molecular Therapeutics Inc Stock on the Dividend Date
If you own 4D Molecular Therapeutics Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of 4D Molecular Therapeutics Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of 4D Molecular Therapeutics Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying 4D Molecular Therapeutics Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the 4D Molecular Therapeutics Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More 4D Molecular Therapeutics Inc Dividends
You can contact us any time if you would like to ask questions about 4D Molecular Therapeutics Inc dividends or anything else related to the stock market.